On the other hand, increased EBNA1 antibody responses in MS may be due to a frustrated EBV-specific immune response, where HLA-DRB1*15:01 is a poor class II allele in the context of EBV immune control. Here, HLA-DRB1 is linked to myeloid sarcoma.